Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo, and seen here in New York 2024 Ian Haddock participated in a trial of lenacapavir. Mandatory Credit: Bryan Bedder/Getty Images via CNN Newsource